Teva wins Netherlands Copaxone case

04-10-2013

Teva wins Netherlands Copaxone case

Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis.


Teva, Copaxone, Mylan, The Hague

LSIPR